lvantis is a healthcare company committed to expanding patient treatment and improving outcomes through new and innovative minimally invasive glaucoma surgical (MIGS) solutions, the fastest growing segment of the ophthalmology market.
For more details on financing and valuation for Ivantis, register or login.
Ivantis does not have a ticker symbol because this company got acquired.
The stock price for Ivantis will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).
To read this article and more news on Ivantis, register or login.